20
Participants
Start Date
October 31, 2015
Primary Completion Date
December 20, 2017
Study Completion Date
November 20, 2018
Viaskin Milk 500 mcg
Biological: Viaskin Milk 500 mcg Subjects epicutaneously administered daily (up to 24 hours application per day) with a patch containing 500 mcg cow's milk proteins.
Viaskin Placebo
Biological: Viaskin Placebo Subjects epicutaneously administered daily (up to 24 hours application per day) with a patch containing a matching placebo formulation.
The Children's Hospital of Philadelphia, Philadelphia
Collaborators (1)
DBV Technologies
INDUSTRY
Children's Hospital of Philadelphia
OTHER